Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Femoral nerve block vs capsular infiltration for analgesia after total knee replacement
2014-005596-90Phase 4Active
- Sponsor
- OLVG West
- Start
- Apr 2015
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of ropivacaine in knee osteoarthritis (OA) (2 arms), sponsored by OLVG West. Primary endpoint: Opioid consumption. Started Apr 2015; status: active.
02
Drugs
ropivacaine
03
Conditions
knee osteoarthritis (OA)
Beyond the preview
Go deeper on 2014-005596-90.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2014-005596-90.